Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® should be used with a reduced-calorie diet and increased physical activity. Click here for full Indications and Usage.
Home / Coverage Options / Learn More About Coverage
To learn how you may be able to gain coverage, and other possible ways to save on your Saxenda® prescriptions, choose from the options below.
Employers decide prescription benefits for their employees. If your company’s plan doesn’t include medicines to treat obesity, don’t be discouraged. You can submit a request for coverage with the help of your health care provider.
Unfortunately, Medicare does not cover medicines for obesity, though they are beginning to offer free counseling sessions for it. Some select Medigap and Medicare Advantage plans for retirees, however, do cover medicines for obesity. If you have one of these plans, please check with its administrator.
There’s a growing movement to get better coverage for weight management and obesity. You can help the cause by learning about and supporting the Treat and Reduce Obesity Act (TROA), to provide more funding and better treatment options for health care providers to address obesity, including intervention, counseling, and drug treatment.
You can help! Urge your Senators and House of Representatives member to cosponsor and support final passage of TROA. Your efforts can make a difference for you and countless other people who need help with treating obesity.
The VA will cover obesity management. See your local Veterans Administration provider to discuss obesity medication options.
Your plan provides coverage for this medication in certain situations. To determine if coverage is available, your doctor may request a coverage review. Please contact your Military Treatment Facility or Tricare Network provider to discuss.
Each state decides for itself what prescription drugs to cover through Medicaid, so you’ll need to contact your state’s Medicaid office to learn if it covers medicines for weight management and obesity.
If you are a city, state, or federal worker, ask your benefits manager about coverage for obesity medications.
Check with your insurance company to learn if you are eligible for an upgrade or an add-on to your plan. And with the possibility of changes to insurance laws, the more you know, the better.
There’s a growing movement to get better coverage for weight management and obesity. You can help the cause by learning about and supporting the Treat and Reduce Obesity Act (TROA), to provide more funding and better treatment options for health care providers to address obesity, including intervention, counseling, and drug treatment.
We need your support! Please urge both of your Senators and your House of Representatives member to cosponsor and support final passage of this important legislation. And include YOUR PERSONAL STORY in a message to help your legislators better understand the need for expanding access to these critical obesity treatment tools.
Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® should be used with a reduced calorie diet and increased physical activity.
Do not share your Saxenda® pen with others even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Serious side effects may happen in people who take Saxenda®, including:
Possible thyroid tumors, including cancer. Tell your health care professional if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Saxenda® and medicines that work like Saxenda® caused thyroid tumors, including thyroid cancer. It is not known if Saxenda® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
Do not use Saxenda® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Do not use Saxenda® if:
Before taking Saxenda®, tell your health care provider about all of your medical conditions, including if you:
Tell your health care provider about all the medicines you take, including prescription, over-the-counter medicines, vitamins, and herbal supplements. Saxenda® slows stomach emptying and can affect medicines that need to pass through the stomach quickly. Saxenda® may affect the way some medicines work and some other medicines may affect the way Saxenda® works. Tell your health care provider if you take diabetes medicines, especially insulin and sulfonylurea medicines.
Saxenda® may cause serious side effects, including:
The most common side effects of Saxenda® in adults include nausea, diarrhea, constipation, vomiting, injection site reaction, low blood sugar (hypoglycemia), headache, tiredness (fatigue), dizziness, stomach pain, and change in enzyme (lipase) levels in your blood. Additional common side effects in children are fever and gastroenteritis.
Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® should be used with a reduced calorie diet and increased physical activity.
Please click here for Prescribing Information and Medication Guide for Saxenda®.
Saxenda® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® should be used with a reduced calorie diet and increased physical activity.
Do not share your Saxenda® pen with others even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Serious side effects may happen in people who take Saxenda®, including:
Possible thyroid tumors, including cancer. Tell your health care professional if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Saxenda® and medicines that work like Saxenda® caused thyroid tumors, including thyroid cancer. It is not known if Saxenda® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
Do not use Saxenda® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Do not use Saxenda® if:
Before taking Saxenda®, tell your health care provider about all of your medical conditions, including if you:
Tell your health care provider about all the medicines you take, including prescription, over-the-counter medicines, vitamins, and herbal supplements. Saxenda® slows stomach emptying and can affect medicines that need to pass through the stomach quickly. Saxenda® may affect the way some medicines work and some other medicines may affect the way Saxenda® works. Tell your health care provider if you take diabetes medicines, especially insulin and sulfonylurea medicines.
Saxenda® may cause serious side effects, including:
The most common side effects of Saxenda® in adults include nausea, diarrhea, constipation, vomiting, injection site reaction, low blood sugar (hypoglycemia), headache, tiredness (fatigue), dizziness, stomach pain, and change in enzyme (lipase) levels in your blood. Additional common side effects in children are fever and gastroenteritis.
Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® should be used with a reduced calorie diet and increased physical activity.
Please click here for Prescribing Information and Medication Guide for Saxenda®.
Saxenda® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.